The hospital is owned by the Episcopal church of Haiti and operates in partnership with the Presbyterian Church (USA).
Learn more about The Good Salt of Haiti, a co-fortified salt social enterprise program.
To support the co-fortified salt project visit giving.nd.edu.
MDA, clinical therapies now administered entirely by HSC
For the past two decades, the Notre Dame Haiti Program has supported efforts by Hopital Sainte Croix (HSC) in Leogane, Haiti, to eliminate lymphatic filariasis (LF) through mass drug administration (MDA) and ease the suffering of Haitians afflicted with the disease through clinical therapies. After many years of success, this work will now be administered entirely by HSC.
The College of Science salutes HSC and its public health reference center, and the progress made to become a top care facility. The LF Clinic at HSC was recently lauded by a representative of the World Health Organization as the only morbidity management and disability prevention clinic of its type in the world. The long-term success of the program, and other partnerships formed along the way, will allow HSC to seamlessly continue operation of the clinic, as well as of the Residence Filariose, a guest house where HSC volunteers, including Notre Dame alumni, often stay. Other global LF elimination partners have signaled intent to sustain the MDA work previously supported by Notre Dame.
“Consistent with Notre Dame’s Catholic mission to be a force for good in the world, the College of Science is honored to have partnered with HSC in the fight to eliminate LF in Haiti. We are heartened that these efforts will continue under HSC’s leadership going forward,” said Mary Galvin, William K. Warren Foundation Dean of the College of Science. “That represents a win-win for HSC and the people of Haiti.”